Behavioral Health Business April 15, 2024
The autism therapy industry comes to today’s moment of massive investment interest and technological innovation while still in its scientific infancy. Consider that Donald Triplett, who is widely regarded as the proverbial “Case 1” of autism as a diagnosed condition, died less than a year ago.
With increased awareness, better diagnostic sensitivity and wider assessment criteria, the U.S. has seen the rate among children balloon to 1 in 36 children as assessed in 2020. It was 1 in 150 in 2000, according to the Autism and Developmental Disabilities Monitoring (ADDM) Network.
In parallel, research and business seek to meet the moment and fill in the knowledge gaps for the care and condition of an increasing number of people.
Here’s...
Today's Sponsors
Today's Sponsor